{"disease":{"id":"female-urogenital-diseases","name":"female urogenital diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04679675","title":"Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":32771,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT05000957","title":"Pelvic Organs Prolapse Treatment Using Neodymium Laser","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":129,"lead_sponsor_name":"MeLSyTech, Ltd","has_results":false},{"nct_id":"NCT04735549","title":"Vulvovaginal Atrophy Correction Using Neodymium Laser","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"MeLSyTech, Ltd","has_results":false},{"nct_id":"NCT06237920","title":"Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false},{"nct_id":"NCT05463081","title":"Clinical Trial of \"Magic Gyno\" Laser Device","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"MeLSyTech, Ltd","has_results":false},{"nct_id":"NCT04566952","title":"Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":68,"lead_sponsor_name":"Xiaoxiang Chen","has_results":false},{"nct_id":"NCT03562897","title":"Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Catalysis SL","has_results":false},{"nct_id":"NCT06676527","title":"Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":39,"lead_sponsor_name":"Jinling Hospital, China","has_results":false},{"nct_id":"NCT04556071","title":"Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":32,"lead_sponsor_name":"Xiaoxiang Chen","has_results":false},{"nct_id":"NCT03996603","title":"Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT03996057","title":"Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Washington University School of Medicine","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}